rel-(2R,3S)-1-Benzhydryl-2-methylazetidin-3-ol

Catalog No. :
ACVWNQ543
CAS No. :
106859-42-1
Molecular Formula :
C17H19NO
Molecular Weight :
253.35

IUPAC Name:(2R,3S)-1-benzhydryl-2-methylazetidin-3-ol

rel-(2R,3S)-1-Benzhydryl-2-methylazetidin-3-ol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$108.00Login to see priceIn stockInquiry
5g95%$323.00Login to see priceIn stockInquiry
10g95%$476.00Login to see priceIn stockInquiry
25g95%$953.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Namerel-(2R,3S)-1-Benzhydryl-2-methylazetidin-3-ol
IUPAC Name(2R,3S)-1-benzhydryl-2-methylazetidin-3-ol
MDL No.MFCD30802675
Molecular FormulaC17H19NO
Molecular Weight253.35
SMILESO[C@@H]1[C@@H](C)N(C(C2=CC=CC=C2)C3=CC=CC=C3)C1
InChI KeyRVJIUWJMJDLQIP-CJNGLKHVSA-N
Synonym(2R,3S)-1-BENZHYDRYL-2-METHYLAZETIDIN-3-OL;1-(DIPHENYLMETHYL)-2-METHYLAZETIDIN-3-OL,TRANS-;trans-1-(diphenylmethyl)-2-methylazetidin-3-ol;3-Azetidinol, 1-(diphenylmethyl)-2-methyl-, (2R,3S)-rel-;trans-1-Benzhydryl-2-methylazetidin-3-ol;rel-(2R,3S)-1-Benzhydryl-2-methylazetidin-3-ol;trans-1-(diphenylmethyl)-2-methylazetidin-3-ol - [D81265]
CAS No.106859-42-1

Safety Data

Pictogram
Corrosive
Signal Word
Gefahr
Hazard Statement(s)
H314
Precautionary Statement(s)
P260-P264-P280-P301+P330+P331-P303+P361+P353-P304+P340-P305+P351+P338-P310-P321-P363-P405-P501

Synthetic Route by SureRoute

1. ACVWNQ543 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACVWNQ543 route product structure diagram
    ACVWNQ543106859-42-1 In Stock
Inquiry

2. ACVWNQ543 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACVWNQ543 route product structure diagram
    ACVWNQ543106859-42-1 In Stock
Inquiry

Comments (0)